Preoperative treatment of Hepatitis C is associated with lower prosthetic joint infection rates in US Veterans
Journal of Arthroplasty Mar 15, 2019
Bendich I, et al. – Via retrospective analysis of 2014-2018 data (n=42,628) from the US Department of Veterans Affairs, investigators assessed whether hepatitis C virus (HCV) is a modifiable risk factor in total joint arthroplasty (TJA) by comparing postoperative complications among patients with and without preoperative HCV treatment. They also determined lower prosthetic joint infection rates among US veterans. The investigators found that 6.0% of TJA patients had HCV, of whom 17.3% had received HCV treatment preoperatively. They noted lower implant infection rates at 90-days and 1-year postoperatively among treated HCV candidates vs untreated individuals. Among HCV-treated patients, odds ratios favored lower infection rates. They found lower rates of pneumonia and urinary tract infection in treated patients.
Sign-up to continue reading. It is free & takes less than 2 mins
45 lakhs+ doctors trust M3 globally
Free & unlimited access to original articles and quizzes
Secure: we never sell your data
Sign up with M3 India to try daily quizzes and take part in competitionsTry M3 India / Log In
Why join our Market Research Panel?
- 10K+ Doctors participated in 40+ Indian and Global studies in 2018
- Average honorarium per study was Rs. 1,600 and total honoraria as high as Rs. 12,000 was earned by a Doctor